Article on March 17, 2023
Indian Pharma To Grow By 6-8% In FY24, Aided By Price Hikes In NLEMs: ICRA
The agency stated that the IPM witnessed a YoY growth of 7.7 per cent in 9M FY2023 supported by a price growth of 6.8 per cent and growth of 2.3 per cent from new product introductions, while volumes declined by 1.2 per cent. ICRA predicts that price increases will remain the primary growth driver for IPM in the near term
Read More
Health Ministry Seeks CERT-In's Aid To Look Into Hacking Attempt On Its Website
CloudSEK further added that the reason behind this target was that the Indian authorities decided not to violate the sanctions imposed against the Russian Federation
Read More
The Need To Strengthen Health Diagnostic Systems In India
So far, diagnostic services have been heavily concentrated in major urban areas due to the prevalence of institutional healthcare, and the clustering of medical professionals. Now, the country has truly woken up to the fact that more is needed
Read More
Critical Considerations For Connected Health Manufacturers
According to one study, 53 per cent of connected medical devices contain critical vulnerabilities that threaten both patient privacy and patient safety. Healthcare institutions are aware of their presence in hackers’ crosshairs, but often overlook upstream supply chain weaknesses when it comes to bolstering device security
Read More
Joint Efforts & Collaborations Key To Make India Tb Free By 2025: Mandaviya
He also urged other corporates, institutions, trade bodies, associations and individuals to come forward and actively support India’s battle against tuberculosis
Read More
Digital Therapeutics Aided 83% Of Patients In Keeping Vitals Under Normal Range Claims Study
During the 90-day interim analysis, patients enrolled in the program demonstrated significant improvement, with 90 per cent adhering to the recommended medication, diet, and exercise regimen
Read More
Dr Nitish Shetty Appointed As CEO Of Aster DM Healthcare India
Dr Nitish Shetty has been appointed as the Chief Executive Officer (CEO) of Aster DM Healthcare India with effect from March 16, 2023, the company said in a regulatory filing
Read More
Godrej Memorial Hospital Introduces Gene Test For 150 Conditions, Traits
The hospital has partnered with HaystackAnalytics, a HealthTech company based out of IIT Bombay, to launch the Health Genometer Smart Plan, a consumer-centric wellness solution developed on a fully automated AI-based bio-informatics platform
Read More
Glenmark Gets USFDA Nod For First-in-human Study For Tumors, Lymphomas
Glenmark Specialty SA, the subsidiary of Glenmark Pharmaceuticals, the global pharmaceuticals company received acceptance from the U.S. Food and Drug Administration (FDA) on its Investigational New Drug (IND) application for GRC 54276 to proceed with a Phase 1/2, first-in-human, clinical study of GRC 54276 for the treatment of patients with advanced solid tumours and lymphomas
Read More